Individualized Functional Connectivity Targeting in aiTBS for Depression
NCT05680727
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT Number: NCT01141387
The primary objective for this study is to assess the impact of a measurement based treatment program (MBT) on Major Depressive Disorder (MDD) remission rates in patients whose primary care provider (PCP) receives monthly patient-reported depression severity reports compared to patients whose PCP does not receive monthly reports.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Measured at baseline
Time frame: Follow-up upto 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Clinical Outcomes in MEasurement-Based Treatment (COMET)
Acronym: COMET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05680727
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT07258485
Depressive Disorder, Depressive Disorder, Major
Phoenix, Arizona, United States
View Trial DetailsNCT06558344
Depressive Disorder, Depressive Disorder, Major
Bellflower, California, United States
View Trial DetailsNCT04533529
Depressive Disorder, Depressive Disorder, Major
Anaheim, California, United States
View Trial Details